Evidence map›Paper›PMID 27917253›Full record

ArticleBiomicrofluidics2016

A modular microfluidic bioreactor with improved throughput for evaluation of polarized renal epithelial cells.

Paul Brakeman, Simeng Miao, Jin Cheng, Chao-Zong Lee, Shuvo Roy, William H Fissell, Nicholas Ferrell

Open access · hybridAbstract read
In one paragraph

Article in Biomicrofluidics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Paul BrakemanDepartment of Pediatrics, University of California , San Francisco, San Francisco, California 94143, USA.
Simeng MiaoDepartment of Biomedical Engineering, Vanderbilt University , Nashville, Tennessee 37232, USA.
Jin ChengDepartment of Medicine, Division of Nephrology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, USA.
Chao-Zong LeeDepartment of Pediatrics, University of California , San Francisco, San Francisco, California 94143, USA.ORCID 0000-0001-9426-9956
Shuvo RoyDepartment of Bioengineering and Therapeutic Sciences, University of California , San Francisco, San Francisco, California 94143, USA.
William H FissellDepartment of Medicine, Division of Nephrology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, USA.
Nicholas FerrellDepartment of Medicine, Division of Nephrology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, USA.
University of California, San Francisco · USVanderbilt University Medical Center · USVanderbilt University · US

Funding

Building an Implantable Artificial KidneyU01EB021214 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISSELL, WILLIAM H, ROY, SHUVO · 2015 to 2018
$6.0M
Protein Handling By Renal Proximal Tubule Epithelial CellsK01DK092357 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FERRELL, NICHOLAS · 2012 to 2016
$608k
NIBIB NIH HHS U01 EB021214NIDDK NIH HHS K01 DK092357
6 · The paper itself

Abstract

Most current microfluidic cell culture systems are integrated single use devices. This can limit throughput and experimental design options, particularly for epithelial cells, which require significant time in culture to obtain a fully differentiated phenotype. In addition, epithelial cells require a porous growth substrate in order to fully polarize their distinct apical and basolateral membranes. We have developed a modular microfluidic system using commercially available porous culture inserts to evaluate polarized epithelial cells under physiologically relevant fluid flow conditions. The cell-support for the bioreactor is a commercially available microporous membrane that is ready to use in a 6-well format, allowing for cells to be seeded in advance in replicates and evaluated for polarization and barrier function prior to experimentation. The reusable modular system can be easily assembled and disassembled using these mature cells, thus improving experimental throughput and minimizing fabrication requirements. The bioreactor consists of an apical microfluidic flow path and a static basolateral chamber that is easily accessible from the outside of the device. The basolateral chamber acts as a reservoir for transport across the cell layer. We evaluated the effect of initiation of apical shear flow on short-term intracellular signaling and mRNA expression using primary human renal epithelial cells (HRECs). Ten min and 5 h after initiation of apical fluid flow over a stable monolayer of HRECs, cells demonstrated increased phosphorylation of extracellular signal-related kinase and increased expression of interleukin 6 (IL-6) mRNA, respectively. This bioreactor design provides a modular platform with rapid experimental turn-around time to study various epithelial cell functions under physiologically meaningful flow conditions.

Identifiers

PMID27917253
PMCPMC5116024
OpenAlexW2555300098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.